Treatment of picornavirus infections

被引:92
作者
Rotbart, HA
机构
[1] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Dept Microbiol, Denver, CO 80262 USA
关键词
picornavirus; therapy; prophylaxis; rhinovirus; enterovirus;
D O I
10.1016/S0166-3542(01)00206-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The picornaviruses are a diverse group of viral pathogens that together comprise the most common causes of infections of humans in the developed world. Within the picornavirus family are three well-known groups of human pathogens-the enteroviruses (including polioviruses, coxsackieviruses, and echoviruses), the rhinoviruses, and the hepatoviruses (including hepatitis A). Recently, the parechoviruses (formerly, echoviruses 22 and 23) have been classified as a fourth genus of human picornaviruses. This article will focus on the enteroviruses and rhinoviruses agents, for which substantial effort has been expended and recent successes reported towards the development of safe and effective antiviral therapy. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:83 / 98
页数:16
相关论文
共 117 条
[1]   Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults [J].
Abdel-Rahman, SM ;
Kearns, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (06) :613-618
[2]   PROFILE OF ENTEROVIRUS DISEASE IN THE 1ST 2 WEEKS OF LIFE [J].
ABZUG, MJ ;
LEVIN, MJ ;
ROTBART, HA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (10) :820-824
[3]   SUPPRESSION OF COLDS IN HUMAN VOLUNTEERS CHALLENGED WITH RHINOVIRUS BY A NEW SYNTHETIC DRUG (R61837) [J].
ALNAKIB, W ;
HIGGINS, PG ;
BARROW, GI ;
TYRRELL, DAJ ;
ANDRIES, K ;
VANDENBUSSCHE, G ;
TAYLOR, N ;
JANSSEN, PAJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) :522-525
[4]   Frequency and natural history of rhinovirus infections in adults during autumn [J].
Arruda, E ;
Pitkaranta, A ;
Witek, TJ ;
Doyle, CA ;
Hayden, FG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (11) :2864-2868
[5]  
BARROW GI, 2001, ANTIVIR CHEM CHEMOTH, V5, P278
[6]   DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES [J].
BERGELSON, JM ;
CHAN, M ;
SOLOMON, KR ;
STJOHN, NF ;
LIN, HM ;
FINBERG, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6245-6248
[7]   Hybrid female matings are directly related to the availability of Rana lessonae and Rana esculenta males in experimental populations [J].
Bergen, K ;
Semlitsch, RD ;
Reyer, HU .
COPEIA, 1997, (02) :275-283
[8]  
BLACK S, 1983, 23 INT C ANT AG CHEM, P140
[9]   AGE DEPENDENCE OF PARALYSIS INDUCED BY ECHOVIRUS TYPE-9 IN INFANT MICE [J].
BULTMANN, BD ;
EGGERS, HJ ;
GALLE, J ;
HAFERKAMP, O .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06) :999-1005
[10]   SCH 48973: A potent, broad-spectrum, antienterovirus compound [J].
Buontempo, PJ ;
Cox, S ;
WrightMinogue, J ;
DeMartino, JL ;
Skelton, AM ;
Ferrari, E ;
Albin, R ;
Rozhon, EJ ;
Girijavallabhan, V ;
Modlin, JF ;
OConnell, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1220-1225